tolmetin has been researched along with naloxone in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (30.77) | 18.7374 |
1990's | 5 (38.46) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Imazu, C; Ishii, K; Motoyoshi, S; Nakamura, H; Shimizu, M; Yokoyama, Y | 1 |
Domer, F | 1 |
Dong, WK; Halpern, LM | 1 |
Gardocki, JF; Muschek, LD; Pruss, TP; Taylor, RJ | 1 |
Imazu, C; Ishii, K; Kadokawa, T; Nakamura, H; Shimizu, M; Yokoyama, Y | 1 |
Tripathi, A; Welch, SP | 1 |
Castañeda-Hernández, G; Flores-Murrieta, FJ; Granados-Soto, V; Hong, E; López-Muñoz, FJ | 1 |
Miranda, HF; Pinardi, G; Sierralta, F | 1 |
Capasso, A; Sorrentino, L | 1 |
1 review(s) available for tolmetin and naloxone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for tolmetin and naloxone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Analgesic activity of a non-steroidal anti-inflammatory agent, tolmetin sodium in experimental animals (author's transl)].
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Blood Pressure; Bradykinin; Dogs; Female; Male; Naloxone; Pyrroles; Rats; Tolmetin | 1979 |
Characterization of the analgesic activity of ketorolac in mice.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Indomethacin; Ketorolac Tromethamine; Male; Mice; Morphine; Naloxone; Reaction Time; Tolmetin; Tromethamine | 1990 |
D-phenylalanine: a putative enkephalinase inhibitor studied in a primate acute pain model.
Topics: Animals; Aspirin; Avoidance Learning; Carboxypeptidases; Drug Interactions; Isomerism; Macaca fascicularis; Male; Morphine; Naloxone; Neprilysin; Pain; Phenylalanine; Protease Inhibitors; Sensory Thresholds; Tolmetin | 1986 |
Evaluation of the analgesic properties of zomepirac.
Topics: Analgesics; Animals; Cattle; Cyclooxygenase Inhibitors; Drug Interactions; Hindlimb; Humans; In Vitro Techniques; Male; Mice; Morphine; Naloxone; Platelet Aggregation; Pyrroles; Reaction Time; Receptors, Opioid; Substance-Related Disorders; Tolmetin | 1980 |
Site of analgesic action of zomepirac sodium, a potent non-narcotic analgesic in experimental animals.
Topics: Alprostadil; Analgesics; Animals; Ascitic Fluid; Bradykinin; Dogs; Hypertension; Injections, Intraventricular; Male; Naloxone; Pain; Prostaglandins E; Pyrroles; Rats; Rats, Inbred Strains; Tolmetin | 1983 |
Blockade of the antinociceptive activity of centrally administered ketorolac by nor-binaltorphimine.
Topics: Analgesia; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Benzoquinones; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, Leucine; Injections, Intraventricular; Ketorolac Tromethamine; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tolmetin; Tromethamine | 1995 |
Evidence against the participation of mu- and kappa-opioid receptors in the analgesic activity of ketorolac in rats.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Ethylketocyclazocine; Female; Ketorolac; Morphine; Movement Disorders; Naloxone; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Time Factors; Tolmetin | 1995 |
Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice.
Topics: Animals; Cecum; Cerebral Ventricles; Indomethacin; Injections, Intraperitoneal; Ketorolac; Mice; Naloxone; Time Factors; Tolmetin | 1993 |
Arachidonic acid and its metabolites are involved in the expression of morphine dependence in guinea-pig isolated ileum.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Cyclooxygenase Inhibitors; Guinea Pigs; Ileum; In Vitro Techniques; Lipoxygenase Inhibitors; Male; Masoprocol; Meloxicam; Morphine; Muscle Contraction; Naloxone; Narcotic Antagonists; Phospholipases A; Phospholipases A2; Quinacrine; Substance-Related Disorders; Thiazines; Thiazoles; Tolmetin | 1997 |